Back to search

Article

Evaluation of Papanicolaou smears in pemphigus vulgaris patients before and after rituximab

2026-01-16

Abstract excerpt

<title>Abstract</title> <p> Background Pemphigus vulgaris (PV) is a potentially fatal autoimmune mucocutaneous blistering disease. Rituximab (RTX) is a chimeric anti-CD20 monoclonal antibody that is increasingly being used and becoming the first-line therapy in the management of PV. Its impact on cervical cytology and human papillomavirus (HPV) infection risk in this population remains unclear. Objectives To p...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bbc92540-a800-5fe4-89fc-19eba89bfef5
DOI
10.21203/rs.3.rs-7912509/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Evaluation of Papanicolaou smears in pemphigus vulgaris patients before and after rituximabDOI 10.21203/rs.3.rs-7912509/v1
Select a neighboring publication to make it the new centre.